These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 30526770)

  • 1. Senotherapeutics: emerging strategy for healthy aging and age-related disease.
    Kim EC; Kim JR
    BMB Rep; 2019 Jan; 52(1):47-55. PubMed ID: 30526770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-senescence compounds: A potential nutraceutical approach to healthy aging.
    Gurău F; Baldoni S; Prattichizzo F; Espinosa E; Amenta F; Procopio AD; Albertini MC; Bonafè M; Olivieri F
    Ageing Res Rev; 2018 Sep; 46():14-31. PubMed ID: 29742452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
    Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
    Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
    Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular senescence, aging, and age-related disease: Special issue of BMB Reports in 2019.
    Lee JS
    BMB Rep; 2019 Jan; 52(1):1-2. PubMed ID: 30638180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the discovery of senolytics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases.
    Matsubayashi S; Ito S; Araya J; Kuwano K
    Front Endocrinol (Lausanne); 2023; 14():1079626. PubMed ID: 37077349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senolytic therapeutics: An emerging treatment modality for osteoarthritis.
    Ansari MM; Ghosh M; Lee DS; Son YO
    Ageing Res Rev; 2024 Apr; 96():102275. PubMed ID: 38494091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90 inhibitors as senolytic drugs to extend healthy aging.
    Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD
    Cell Cycle; 2018; 17(9):1048-1055. PubMed ID: 29886783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell-derived extracellular vesicles reduce senescence and extend health span in mouse models of aging.
    Dorronsoro A; Santiago FE; Grassi D; Zhang T; Lai RC; McGowan SJ; Angelini L; Lavasani M; Corbo L; Lu A; Brooks RW; Garcia-Contreras M; Stolz DB; Amelio A; Boregowda SV; Fallahi M; Reich A; Ricordi C; Phinney DG; Huard J; Lim SK; Niedernhofer LJ; Robbins PD
    Aging Cell; 2021 Apr; 20(4):e13337. PubMed ID: 33728821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
    Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
    Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging senolytic agents derived from natural products.
    Li W; Qin L; Feng R; Hu G; Sun H; He Y; Zhang R
    Mech Ageing Dev; 2019 Jul; 181():1-6. PubMed ID: 31077707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs and benefits of senotherapeutics for human health.
    Raffaele M; Vinciguerra M
    Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
    Saleh T; Carpenter VJ
    Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-targeted senotherapeutic interventions.
    Atayik MC; Çakatay U
    Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.